GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » Price-to-Free-Cash-Flow

BZYR (Burzynski Research Institute) Price-to-Free-Cash-Flow : N/A (As of Apr. 13, 2025)


View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute Price-to-Free-Cash-Flow?

As of today (2025-04-13), Burzynski Research Institute's share price is $0.045. Burzynski Research Institute's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.00. Hence, Burzynski Research Institute's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Burzynski Research Institute's Price-to-Free-Cash-Flow or its related term are showing as below:

BZYR's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Burzynski Research Institute's Free Cash Flow per Share for the three months ended in Nov. 2024 was $-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -10.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 6.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -1.20% per year.

During the past 13 years, Burzynski Research Institute's highest 3-Year average Free Cash Flow per Share Growth Rate was 29.10% per year. The lowest was -26.00% per year. And the median was 8.15% per year.


Burzynski Research Institute Price-to-Free-Cash-Flow Historical Data

The historical data trend for Burzynski Research Institute's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute Price-to-Free-Cash-Flow Chart

Burzynski Research Institute Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Burzynski Research Institute Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Burzynski Research Institute's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Burzynski Research Institute's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burzynski Research Institute's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Price-to-Free-Cash-Flow falls into.


;
;

Burzynski Research Institute Price-to-Free-Cash-Flow Calculation

Burzynski Research Institute's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.045/-0.003
=N/A

Burzynski Research Institute's Share Price of today is $0.045.
Burzynski Research Institute's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Burzynski Research Institute  (OTCPK:BZYR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Burzynski Research Institute Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Burzynski Research Institute Business Description

Traded in Other Exchanges
N/A
Address
9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Executives
Monika Szopa-paszkowiak director 9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff director 9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski director, 10 percent owner 9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood director 9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski officer: Secretary and Treasurer 9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski director 9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki officer: VP of Clinical Trials 9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll director 9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski director, 10 percent owner, officer: President 9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson officer: Chief Financial Officer 9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute Headlines

No Headlines